283 related articles for article (PubMed ID: 34699191)
1. Drug Loading of Anthracycline Antibiotics on Carbon Dots Using Circular Dichroism Spectrometry.
Ferreira BCLB; Liyanage PY; Leblanc RM
Anal Chem; 2021 Nov; 93(44):14773-14777. PubMed ID: 34699191
[TBL] [Abstract][Full Text] [Related]
2. Cancer-Targeted Controlled Delivery of Chemotherapeutic Anthracycline Derivatives Using Apoferritin Nanocage Carriers.
Kurzątkowska K; Pazos MA; Herschkowitz JI; Hepel M
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33572999
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the interaction of doxorubicin, daunorubicin, idarubicin and idarubicinol with large unilamellar vesicles. Circular dichroism study.
Gallois L; Fiallo M; Garnier-Suillerot A
Biochim Biophys Acta; 1998 Mar; 1370(1):31-40. PubMed ID: 9518541
[TBL] [Abstract][Full Text] [Related]
4. [Cardiooncology: Current Aspects of Prevention of Anthracycline Toxicity].
Vasyuk YA; Shkolnik EL; Nesterov VV; Shkolnik LD; Varlan GV
Kardiologiia; 2016 Dec; 56(12):72-79. PubMed ID: 28290807
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacokinetics of new anthracyclines].
Robert J
Bull Cancer; 1988; 75(2):167-74. PubMed ID: 3282579
[TBL] [Abstract][Full Text] [Related]
6. Structure-dependent complexation of Fe3+ by anthracyclines. 1. The importance of pendent hydroxyl functionality.
Nawara K; McCracken JL; Krysiński P; Blanchard GJ
J Phys Chem B; 2013 Jun; 117(23):6859-67. PubMed ID: 23692060
[TBL] [Abstract][Full Text] [Related]
7. Studies of anthracycline--DNA complexes by circular dichroism.
Rizzo V; Penco S; Menozzi M; Geroni C; Vigevani A; Arcamone F
Anticancer Drug Des; 1988 Aug; 3(2):103-15. PubMed ID: 3165639
[TBL] [Abstract][Full Text] [Related]
8. Preparation and in Vitro Analysis of Human Serum Albumin Nanoparticles Loaded with Anthracycline Derivatives.
Kimura K; Yamasaki K; Nakamura H; Haratake M; Taguchi K; Otagiri M
Chem Pharm Bull (Tokyo); 2018; 66(4):382-390. PubMed ID: 29607904
[TBL] [Abstract][Full Text] [Related]
9. Inclusion complexation of doxorubicin and daunorubicin with cyclodextrins.
Bekers O; Beijnen JH; Otagiri M; Bult A; Underberg WJ
J Pharm Biomed Anal; 1990; 8(8-12):671-4. PubMed ID: 2100605
[TBL] [Abstract][Full Text] [Related]
10. Phase I and II agents in cancer therapy: I. Anthracyclines and related compounds.
Wadler S; Fuks JZ; Wiernik PH
J Clin Pharmacol; 1986; 26(7):491-509. PubMed ID: 2944917
[TBL] [Abstract][Full Text] [Related]
11. RNA targeting by an anthracycline drug: spectroscopic and
Charak S; Shandilya M; Mehrotra R
J Biomol Struct Dyn; 2020 Apr; 38(6):1761-1771. PubMed ID: 31084352
[TBL] [Abstract][Full Text] [Related]
12. Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase.
Davies KJ; Doroshow JH
J Biol Chem; 1986 Mar; 261(7):3060-7. PubMed ID: 3456345
[TBL] [Abstract][Full Text] [Related]
13. The mechanism for anthracycline-induced inhibition of collagen biosynthesis.
Muszyńska A; Wolczyński S; Pałka J
Eur J Pharmacol; 2001 Jan; 411(1-2):17-25. PubMed ID: 11137854
[TBL] [Abstract][Full Text] [Related]
14. Spectroscopic and cytotoxicity studies on the combined interaction of (-)-epigallocatechin-3-gallate and anthracycline drugs with human serum albumin.
Guo Q; Liu M; Zhao Y; Wu Y; Liu J; Cai C; Shi Y; Han J
Spectrochim Acta A Mol Biomol Spectrosc; 2019 Nov; 222():117213. PubMed ID: 31177010
[TBL] [Abstract][Full Text] [Related]
15. Development of the model of rat isolated perfused heart for the evaluation of anthracycline cardiotoxicity and its circumvention.
Pouna P; Bonoron-Adèle S; Gouverneur G; Tariosse L; Besse P; Robert J
Br J Pharmacol; 1996 Apr; 117(7):1593-9. PubMed ID: 8730759
[TBL] [Abstract][Full Text] [Related]
16. [Modern imaging techniques for anthracycline cytostatics - review of the literature].
Blažková I; Ryvolová M; Křížková S; Jílková E; Kopel P; Eckschlager T; Stiborová M; Adam V; Kizek R
Klin Onkol; 2013; 26(4):239-44. PubMed ID: 23961853
[TBL] [Abstract][Full Text] [Related]
17. Profound Nanoscale Structural and Biomechanical Changes in DNA Helix upon Treatment with Anthracycline Drugs.
Kaczorowska A; Lamperska W; Frączkowska K; Masajada J; Drobczyński S; Sobas M; Wróbel T; Chybicka K; Tarkowski R; Kraszewski S; Podbielska H; Kałas W; Kopaczyńska M
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32531996
[TBL] [Abstract][Full Text] [Related]
18. Chemometric Analysis of UV-Visible Spectral Fingerprints for the Discrimination and Quantification of Clinical Anthracycline Drug Preparation Used in Oncology.
El Orche A; Adade CA; Mefetah H; Cheikh A; Karrouchi K; El Karbane M; Bouatia M
Biomed Res Int; 2021; 2021():5580102. PubMed ID: 34041297
[TBL] [Abstract][Full Text] [Related]
19. Nuclear targeting and nuclear retention of anthracycline-formaldehyde conjugates implicates DNA covalent bonding in the cytotoxic mechanism of anthracyclines.
Taatjes DJ; Fenick DJ; Koch TH
Chem Res Toxicol; 1999 Jul; 12(7):588-96. PubMed ID: 10409398
[TBL] [Abstract][Full Text] [Related]
20. Circular dichroism studies on anthracycline antitumor compounds. Relationship between the molecular structure and the spectroscopic data.
Fiallo MM; Tayeb H; Suarato A; Garnier-Suillerot A
J Pharm Sci; 1998 Aug; 87(8):967-75. PubMed ID: 9687341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
